Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.

Literature DB >> 7104160

Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.

P Baumann, D Tinguely, J Schöpf.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1982 PMID： 7104160 PMCID： PMC1427590 DOI： 10.1111/j.1365-2125.1982.tb04942.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

7 in total

1. The dye-binding capacity of human plasma determined fluorimetrically and its relation to the determination of plasma albumin.

Authors: V H REES; J E FILDES; D J LAURENCE
Journal: J Clin Pathol Date: 1954-11 Impact factor: 3.411

2. Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components.

Authors: M H Bickel
Journal: J Pharm Pharmacol Date: 1975-10 Impact factor: 3.765

3. [Determination of the plasma concentration and antidepressive effect of amitriptyline].

Authors: R Volmat; P Bechtel; G Allers; B Vandel; S Vandel
Journal: Therapie Date: 1977 May-Jun Impact factor: 2.070

4. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors: K M Piafsky; O Borgå
Journal: Clin Pharmacol Ther Date: 1977-11 Impact factor: 6.875

5. Amitriptyline plasma levels and therapeutic response.

Authors: V E Ziegler; B T Co; J R Taylor; P J Clayton; J T Biggs
Journal: Clin Pharmacol Ther Date: 1976-06 Impact factor: 6.875

6. Plasma tricyclic drug levels in amitriptyline-treated depressed patients.

Authors: D S Robinson; T B Cooper; C L Ravaris; J O Ives; A Nies; D Bartlett; K R Lamborn
Journal: Psychopharmacology (Berl) Date: 1979-06-21 Impact factor: 4.530

7. Lignocaine disposition in blood in epilepsy.

Authors: P A Routledge; W W Stargel; A L Finn; A Barchowsky; D G Shand
Journal: Br J Clin Pharmacol Date: 1981-11 Impact factor: 4.335

7 in total

8 in total

Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.

1. The dye-binding capacity of human plasma determined fluorimetrically and its relation to the determination of plasma albumin.

2. Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components.

3. [Determination of the plasma concentration and antidepressive effect of amitriptyline].

4. Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

5. Amitriptyline plasma levels and therapeutic response.

6. Plasma tricyclic drug levels in amitriptyline-treated depressed patients.

7. Lignocaine disposition in blood in epilepsy.

Review 1. Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

2. Influence of menstrual cycle phase on serum concentrations of alpha 1-acid glycoprotein.

3. The plasma protein binding of basic drugs.

Review 4. Clinical pharmacokinetics of imipramine and desipramine.

Review 5. Free drug concentration monitoring in clinical practice. Rationale and current status.

Review 6. Clinical pharmacokinetic considerations in the elderly. An update.

7. Cimetidine does not increase alpha 1-acid glycoprotein serum concentrations.

8. The impact of the COVID-19 pandemic on wellbeing and cognitive functioning of older adults.